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Background: Acquired demyelinating disorders of the central nervous system are diverse group of conditions characterized 
by destruction or disturbance of myelin sheath in the central nervous system i.e. brain and spinal cord. These vary in their 
causes, clinical presentations, and prognosis. Objective: To study the spectrum of acquired demyelinating disorders of 
central nervous systemin adults in a tertiary care hospital of Pakistan. Materials and Methods: This is a retrospective cross 
sectional descriptive study carried out at department of Neurology, King Edward Medical University/ Mayo hospital, Lahore. 
Study period was one year from March 2012 till February 2013. Medical records of the patients with history of focal or multi-
focal neurological deficits suspected of demyelinating disorders were reviewed. Those fulfilling the diagnostic criteria for 
specific demyelinating disorder were included in the study. Clinical, laboratory and radiological features were recorded on a 
specific proforma designed for the study. Results were analyzed using SPSS version 17. Results: During this period seventy 
one patients with various demyelinating disorders were diagnosed. There were 39 (55%) males and 32(45%) females with 
M: F ratio of 1.2:1.The mean age at presentation was29.5+ 9.3 years. Thirty four (48%) patients were diagnosed as 
clinically isolated syndrome (CIS), 23(32%) as multiple sclerosis (MS), 8(11.2%) as neuromyelitis optica (NMO), and 
2(2.8%) as acute disseminated encephalomyelitis (ADEM). There was one case (1.5%) of each of the following disorders: 
progressive multifocal leukoencephalopathy (PML); vitamin B12 deficiency with dorsal myelopathy; post cardiac arrest 
hypoxic/ischemic symmetrical demyelination affecting basal ganglia; and central pontine myelinolysis (CPM). Out of the 34 
cases of CIS, 17(50%) cases presented as transverse myelitis, 14(41%) optic neuritis, 2(6%) cerebellitis, and 1(3%) mutlifo-
cal CIS. Among 23 cases of multiple sclerosis, 17(74%) had relapsing and remitting course (RRMS), 4(18%) primary 
progressive (PPMS), and 2(9%) secondary progressive course (SPMS). Conclusion: Demyelinating disorders are not uncom-
mon in our local population. Inflammatory demyelinating disorders are more common than non-inflammatory causes. Mono-
focal clinically isolated syndrome (CIS) remained the most common form of inflammatory demyelination especially transverse 
myelitis followed by optic neuritis. Frequency of relapsing remitting multiple sclerosis was 74% and neuromyelitis optica was 
11.2% in our local population.  ADEM was rare (< 2.8%) in our adults population.
KEY WORDS: Clinically isolated syndrome (CIS), multiple sclerosis (MS), neuromyelitis optica (NMO), acute dissemi-
nated encephalomyelitis (ADEM), progressive multifocal leukoencephalopathy (PML)
INTRODUCTION
The term demyelination describes a loss of myelin with relative preservation of axons.1 The etiology of acquired demyelinating 
disorder is multi-factorial.1 However, traditionally known major group in this category comprised of immune mediated inflam-
matory demyelination with resultant wide spectrum of clinical syndromes such as multiple sclerosis (MS) and acute dissemi-
nated encephalomyelitis (ADEM).2-7 Other less common causes of acquired demyelinating disorders include infections (such 
as progressive multifocal leukoencephalopathy), drugs and toxins (such as tin, lead, isoniazid and radiation), nutritional 
deficiencies (such as B12 deficiency), and acquired metabolic disturbances (such as osmotic demyelination causing pontine 
and extra-pontine myelinolysis).8-12 These demyelinating disorders are recognized by their clinical presentation which may be  
monofocal or multifocal onset, course such as monophasic or polyphasic/relapsing, and specific neuro-imaging features of 
brain and spinal cord. Other investigations such as cerebrospinal fluid analysis, serum electrolytes, serum B12 and toxic 
screening may help in reaching the correct diagnosis.13,14 Consensus definitions and criteria are available for the diagnosis 
of most inflammatory demyelinating disorders such as MS,ADEM and NMO.15-17 We undertook this study to find out the spec-
trum of  acquired demyelinating disorders of central nervous system in adults in a tertiary care hospital of Pakistan. 
MATERIALS AND METHODS
This is a retrospective cross sectional descriptive study carried out at department of Neurology, King Edward Medical 
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University/Mayo hospital, Lahore. Study period was one year from March 2012 till February 2013. Medical records of the 
patients with history of focal or multifocal neurological deficits suspected of demyelinating disorders were reviewed. Inclu-
sion criteria were: age >13 years; both sexes (male and female) and; symptoms/signs and MRI findings consistent withan 
acquired demyelinating disorder. Multiple sclerosis was diagnosed according to revised McDonald’s diagnostic criteria 
2010.16Clinically isolated syndrome (CIS) was defined as first acute clinical episode of CNS symptoms (without encepha-
lopathy) with a presumed inflammatory demyelinating cause without any prior history of a demyelinating event.CIS was 
further classified into monofocal onset when the symptoms localized to a single site in CNS   such as optic neuritis, trans-
verse myelitis, isolated hemiplegic syndrome etc and multifocal onset when the symptoms localized to multiple CNS sites 
but without history of encephalopathy and fever. Neuromyelitis optica was diagnosed according to the revised diagnostic 
criteria by Wingerchuk et al. (2006). 17 Acute disseminated encephalomyelitis (ADEM) was diagnosed and classified 
according to International Pediatric MS Study Group-Consensus Definitions criteria with multifocal CNS white matter 
involvement associated with encephalopathy. Progressive multifocal leukoencephalopathy (PML) was diagnosed on the 
basis of clinical history, evidence of immunosuppresion, and MRI findings suggestive of PML. Central pontine and extra-
pontinemyelinolysis was diagnosed with evidence of white matter lesion on MRI brain in the setting of severe hypona-
tremia and its rapid correction. Exclusion criteria included: (1) age<13 years; (2) Ischemic demyelination (i.e. lacunar 
infarcts, Biswegner’s disease and age related periventricular ischemic leukoencephalopathy; (3) Radiation induced white 
matter lesions; (4) Reversible posterior leukoencephalopathy syndrome (RPLS); and (5) Leukodystrophy. Those fulfilling 
the diagnostic criteria for specific demyelinating disorder were included in the study. Clinical, laboratory and radiological 
features were recorded on a specific proforma designed for the study. Results were analyzed using SPSS version 17.
RESULTS
During this period seventy one patients with various demyelinating disorders were diagnosed. There were 39 (55%) 
males and 32(45%) females with M: F ratio of 1.2:1. The mean age at presentation was 29.5+ 9.3 years. Thirty four 
(48%) patients were diagnosed as clinically isolated syndrome (CIS), 23(32%) as multiple sclerosis (MS), 8(11.2%) as 
neuromyelitis optica (NMO), and 2(2.5%) as acute disseminated encephalomyelitis (ADEM) {Table 1}. There was one 
case (1.5%) of each of the following disorders: progressive multifocal leukoencephalopathy (PML); vitamin B12 
deficiency with dorsal myelopathy; post cardiac arrest hypoxic/ischemic symmetrical demyelination affecting basal 
ganglia; and central pontine myelinolysis (CPM). Out of the 34 cases of CIS, 17 (50%) cases presented as transverse 
myelitis, 14(41%) optic neuritis, 2(6%) cerebellitis, and 1(3%) mutlifocal CIS (Table 2). Among 23 cases of multiple 
sclerosis, 17(74%) had relapsing and remitting course (RRMS), 4(18%) primary progressive (PPMS), and 2(9%) 
secondary progressive form (SPMS) {Table 3}. 
CIS,  clinically isolated syndrome; MS, multiple sclerosis; NMO,  neuromyelitis optica; ADEM,  acute disseminated 
encephalomyelitis; PML= progressive multifocal leucoencephalopathy
 
Diagnosis of 
demyelinating disorder  
 
Frequency  
n (%)  
 
Males  
n (%)  
 
Females  
n (%)  
 
M:F  
C.I.S  34  (48 ) 21 (61),   13 (39)  1.6:1  
MS  23  (32 ) 11 (48)   12 (52)  1 : 1  
NMO  08(1 1.2)  03(37.5)  05(62.5)  1:2.6  
ADEM  02(2.8)  01(50)  01(50)  1:1  
PML  01(1.5)  01(100)  0 1:0  
B12 deficiencydorsal  
cord demyelination  
01(1.5)  01(100)  0 1:0  
Osmotic demyelination 
(CPM)  
01(1.5)  01(100)  0 1:0  
Hypoxic/ischemic 
demyelination  
01(1.5)  0 01(100)  0:1 
 
Table 1. Spectrum of demyelinating disorders ( N=71)
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DISCUSSION
This is the first study from Pakistan addressing the whole spectrum of acquired demyelinating disorders (inflammatory and 
non-inflammatory) of the central nervous system in adults. In our study the mean age at presentation was 29.5+ 9.3 with 
F: M ratio of 1.2:1.In a prospective, population-based sample of 1424 patients with multiple sclerosis in South-East 
Wales, the age at onset was 31. 2 years in male,  29.3 in female and F:M ratios were highest <16 years of age and 
declined with increasing age, with a male excess in those over 50.18 In our study the most common form of acquired 
demyelinating disorder was inflammatory demyelination. More over, the most common form of inflammatorydemyelination 
was CIS (50%) followed by multiple sclerosis (34%) and ADEM (2.5%). In comparison,Wu J.S etal. in their study retro-
spectively reviewed 842 cases over 12 years and showed that MS was the most common demyelinating disorder (83.5%) 
followed by CIS (10.9%) and ADEM (1.9%).19The high incidence of CIS in our study may be due to short period of review 
which was one year. With longer follow up some of the CIS cases may show conversion to definite MS or NMO as studies 
has shown that 30 to 70% of persons experiencing CIS later develop MS.20 In a Dutch study on acquired demyelinating 
disorder (ADS) in children, most patients presented with polyfocal ADS without encephalopathy (30%), followed by polyfo-
cal ADS with encephalopathy (24%), optic neuritis (ON, 22%), monofocal ADS (16%), transverse myelitis (3%), and 
neuromyelitis optica (3%).21In our study,  most common presentation of CIS was monofocal with transverse myelitis in 
50% of casesfollowed by optic neuritis (41.2%) and cerebellitis (5.9%) respectively. In our study frequency of polyfocal 
CIS was only 2.9%. The most common presentations of acquired demyelination of the CNS in Canadian children were 
optic neuritis (ON; n = 51, 23%), acute disseminated encephalomyelitis (ADEM; n = 49, 22%), and transverse myelitis 
(TM; n = 48, 22%).22 Most common type of MS, according to the course of disease, was relapsing and remitting form 
(74%) in our study. This is slightly lower than previously reported (80-85%). 23In contrast, the frequency of primary 
progressive MS was 18% in our study which is in accordance with previous reports (15-20%). 24
The frequency of NMO was 11.8% in our study which is generally considered a rare disease in white populations and 
occurs much more commonly in nations with a predominately nonwhite population. The frequency of NMO was 6.8% 
in São Paulo and 20.5% in Rio de Janeiro, and mainly seen in persons of African descent in a Brazilian multiple sclero-
sis (MS) survey performed from 1995-1998. 24 Selective involvement of the optic nerves and spinal cord has been 
reported up to 15-40% from Japan and 36% from Hong Kong.25, 26 In contrast, in countries consisting predominately 
of a white population, NMO comprised less than 2% of all demyelinating disorders.18 F:M ratio was 2.6 : 1 in our study 
but much higher preponderance in female up to 9:1 in relapsing form of NMO has been reported. 27 The other types 
of acquired non inflammatory demyelinating disorders were rare in our study. To our knowledge there has been no 
published study till to date addressing the overall spectrum of acquired demyelinating disorders in adults with inclusion 
of both inflammatory and non-inflammatory causes of demyelination.
CONCLUSION
In conclusion, the demyelinating disorders are not uncommon in our local population. Inflammatory demyelinating 
disorders are more common than non-inflammatory demyelination. Monofocal CIS remained most common form of 
inflammatory demyelination especially transverse myelitis followed by optic neuritis. Frequency of RRMS was 74% and 
NMO 12% in our local population. ADEM was rare (< 2.5%) in our adults population. However, larger studies over 
longer period are required to confirm these findings and to observe the further conversion of CIS cases into MS or NMO.
Table 2. Frequency of various presentations of clinically isolated syndrome (n=34)





n(%)    
Transverse Myelitis  17(50%)  17(24%)  
Optic Neuritis  14(41.2%)  14(20%)  
Cerebellitis  02(5.9%)  02(2.8%)  
Multifocal  01(2.9%)  01(1.4%)  
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